tiprankstipranks
Diagonal Bio AB (DE:9F1)
FRANKFURT:9F1
Germany Market

Diagonal Bio AB (9F1) Financial Statements

0 Followers

Diagonal Bio AB Financial Overview

Diagonal Bio AB's market cap is currently ―. The company's EPS TTM is €-0.198; its P/E ratio is -0.11; Diagonal Bio AB is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenuekr 0.00kr 0.00kr 51.00Kkr 153.00Kkr 153.00K
Gross Profitkr 236.00Kkr 903.00Kkr 498.00Kkr 418.00Kkr -74.00K
EBITkr -3.94Mkr -3.51Mkr -4.34Mkr -3.38Mkr -3.57M
EBITDAkr -3.94Mkr -3.51Mkr -4.34Mkr -3.38Mkr -3.57M
Net Income Common Stockholderskr -4.19Mkr -3.76Mkr -4.85Mkr -3.38Mkr -3.57M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investmentskr 13.59Mkr 10.77Mkr 16.43Mkr 16.92Mkr 20.77M
Total Assetskr 34.03Mkr 29.77Mkr 33.73Mkr 32.70Mkr 36.01M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -13.59Mkr -10.77Mkr -16.43Mkr -16.92Mkr -20.77M
Total Liabilitieskr 2.78Mkr 7.88Mkr 8.09Mkr 2.21Mkr 2.14M
Stockholders Equitykr 31.25Mkr 21.89Mkr 25.64Mkr 30.49Mkr 33.87M
Cash Flow-
Free Cash Flowkr -5.73Mkr -5.67Mkr -4.21Mkr -3.34Mkr -11.51M
Operating Cash Flowkr -4.40Mkr -3.83Mkr -4.21Mkr -3.34Mkr -2.92M
Investing Cash Flowkr -1.33Mkr -1.84Mkr -1.28Mkr -509.00Kkr -1.21M
Financing Cash Flowkr 8.55Mkr 0.00kr 5.00Mkr 0.00kr 0.00
Currency in SEK

Diagonal Bio AB Earnings and Revenue History

Diagonal Bio AB Debt to Assets

Diagonal Bio AB Cash Flow

Diagonal Bio AB Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis